Research progress of sodium-glucose cotransporter 2 inhibitors in the treat-ment of diabetic retinopathy

VernacularTitle:钠-葡萄糖协同转运蛋白2抑制剂治疗糖尿病视网膜病变的研究进展
Author: Weiwen ZOU ¹ ; Ruxue LEI ; Hui HUANG ; Yanlin ZHENG
Author Information

1. 610075 四川省成都市,成都中医药大学
Keywords: sodium-glucose cotransporter 2 inhibitors; diabetic retinopathy; research progress
From: Recent Advances in Ophthalmology 2024;44(1):71-75
CountryChina
Language:Chinese
Abstract: Diabetic retinopathy(DR)is a common complication of diabetes.Sodium-glucose cotransporter 2(SGLT-2)inhibitors are widely used in diabetic patients as hypoglycemic drugs and also play a role in the prevention and treatment of DR.At present,there has been no systematic study on the clinical treatment of DR by SGLT-2 inhibitors.This paper re-views the research progress of SGLT-2 inhibitors in the treatment of DR,in order to provide more ideas for the clinical treatment of DR.